AstraZeneca’s top executive in China, Leon Wang, has been detained by Chinese authorities over the past week, the drugmaker told the Financial Times.
The FTSE 100 company confirmed that the head of its China business is in detention, while two other current executives in the region and two former executives are under investigation.
The investigation relates to the alleged illegal importation and sale of cancer drug Imjudo and Wang is among the individuals detained in connection with the probe, according to a person familiar with the matter.
您已阅读24%（545字），剩余76%（1713字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。